DEVELOPING A BETTER UNDERSTANDING OF CANNABINOIDS

CBD has become a blanket descriptor for a range of chemical compounds that HME providers and DME pharmacies should more closely comprehend in order to help their clients.

As the public’s acceptance of cannabis products continue to grow, and more states are decriminalizing medical and/or recreational cannabis consumption, a growing number of consumers have been looking to CBD (cannabidiol) and hemp products in hopes of alleviating pain and inflammation, anxiety, and insomnia. 

It is important to note that “CBD” has become a blanket term for therapeutic hemp products and that CBD is just one of the currently 160+ identified potentially therapeutic cannabinoids.  

Check out the full article at: HME business here!